Paul E Harris

About Paul E Harris

Paul E Harris, With an exceptional h-index of 43 and a recent h-index of 19 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of Diabetes Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine

Survivin expression in luminal breast cancer and adjacent normal tissue for immuno-oncology applications

Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron

Survivin (BIRC5) peptide vaccine in the 4T1 murine mammary tumor model: a potential neoadjuvant T cell immunotherapy for triple negative breast cancer: a preliminary study

Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing

T-cell targeted immunotherapy against the tumor associated antigen survivin (BIRC5) as a potential neoadjuvant immunotherapy for triple negative breast cancer

Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5‐HT1A Receptor

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

Paul E Harris Information

University

Position

Columbia University Medical Center

Citations(all)

6514

Citations(since 2020)

1170

Cited By

6158

hIndex(all)

43

hIndex(since 2020)

19

i10Index(all)

93

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Paul E Harris Skills & Research Interests

Diabetes Immunology

Top articles of Paul E Harris

Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine

Vaccines

2024/3/18

Paul E Harris
Paul E Harris

H-Index: 22

Survivin expression in luminal breast cancer and adjacent normal tissue for immuno-oncology applications

International Journal of Molecular Sciences

2023/7/23

Sharon Wright
Sharon Wright

H-Index: 15

Paul E Harris
Paul E Harris

H-Index: 22

Analysis of well-annotated next-generation sequencing data reveals increasing cases of SARS-CoV-2 reinfection with Omicron

Communications Biology

2023/3/18

Daria Mochly-Rosen
Daria Mochly-Rosen

H-Index: 45

Paul E Harris
Paul E Harris

H-Index: 22

Survivin (BIRC5) peptide vaccine in the 4T1 murine mammary tumor model: a potential neoadjuvant T cell immunotherapy for triple negative breast cancer: a preliminary study

Vaccines

2023/3/13

Paul E Harris
Paul E Harris

H-Index: 22

Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing

medRxiv

2022/9/14

Daria Mochly-Rosen
Daria Mochly-Rosen

H-Index: 45

Paul E Harris
Paul E Harris

H-Index: 22

T-cell targeted immunotherapy against the tumor associated antigen survivin (BIRC5) as a potential neoadjuvant immunotherapy for triple negative breast cancer

bioRxiv

2022/7/25

Paul E Harris
Paul E Harris

H-Index: 22

Design, Synthesis, and Characterization of a Novel Fluoroprobe for Live Human Islet Cell Imaging of Serotonin 5‐HT1A Receptor

ChemMedChem

2022/5/18

Paul E Harris
Paul E Harris

H-Index: 22

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome

Drug Repurposing for COVID-19 Therapy

2021/10/14

Paired SARS-CoV-2 spike protein mutations observed during ongoing SARS-CoV-2 viral transfer from humans to minks and back to humans

Infection, Genetics and Evolution

2021/9/1

A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques

Vaccines

2021/5/18

The radiolabeling of a gly-sar dipeptide derivative with flourine-18 and its use as a potential peptide transporter pet imaging agent

Molecules

2020/2/2

New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion

Molecular psychiatry

2020/9

An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 …

Vaccine

2020/6/9

PET imaging of pancreatic dopamine D2 and D3 receptor density with 11C-(+)-PHNO in type 1 diabetes

Journal of Nuclear Medicine

2020/4/1

See List of Professors in Paul E Harris University(Columbia University in the City of New York)